CORRECTION: Eevia Health Plc: Notice for Annual General Meeting for June 28, 2024

THE NOTICE FOR THE AGM WAS SENT OUT WITH THE MAR LABEL, WHICH IS INCORRECT. THEREFORE, WE RESEND THE NOTICE WITHOUT THE MAR LABEL.

Eevia Health Plc, (”Eevia” or ”The Company”), has today published the notice for the Annual General Meeting of Shareholders (“AGM”) for June 28, 2024. The AGM will be held at the main office in Seinäjoki, Finland.

For immediate release

Seinäjoki, Finland 10.06.2024

Eevia Health Plc, (”Eevia” or ”The Company”), has today published the notice for the Annual General Meeting of Shareholders (“AGM”) for June 28, 2024. The AGM will be held at the main office in Seinäjoki, Finland.

The call for the AGM is made today, June 10th, 2024. The Record date is 17.6.2024. The market deadline for custodians to do temporary registrations is 24.6.2024 at 10:00 (Finnish time). All relevant information for the AGM, including details on how to participate, can be found in the notice, which may also be found together with relevant documents at the current site: https://investor.eeviahealth.com/corporate-governance/general-meetings/

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com                      

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth.